#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA652980	F	Evaluation of titer of virus progeny produced in untreated infected cells and in cells treated with the compound by plaque assay on BSC-1 cells.	Cercopithecidae	8		cell-based format	Scientific Literature
2.	ALA651384	B	The apparent DNA binding constant to bind with calf thymus DNA was determined by ethidium displacement assay	Bos taurus	2		nucleic acid format	Scientific Literature
3.	ALA653790	F	Inhibitory concentration required to inhibit human T-lymphoblast CEM cells proliferation	Homo sapiens	18		cell-based format	Scientific Literature
4.	ALA662221	B	In vitro ability to inhibit HSV DNA polymerase activity in vitro using activated calf thymus DNA as atemplate at dose 100 ug/mL	herpes simplex virus	7		nucleic acid format	Scientific Literature
5.	ALA662222	B	In vitro ability to inhibit HSV DNA polymerase activity in vitro using activated calf thymus DNA as atemplate at dose 200 ug/mL	herpes simplex virus	7		nucleic acid format	Scientific Literature
6.	ALA662223	B	In vitro ability to inhibit HSV DNA polymerase activity in vitro using activated calf thymus DNA as atemplate at dose 25 ug/mL	herpes simplex virus	7		nucleic acid format	Scientific Literature
7.	ALA662224	B	In vitro ability to inhibit HSV DNA polymerase activity in vitro using activated calf thymus DNA as atemplate at dose 400 ug/mL	herpes simplex virus	7		nucleic acid format	Scientific Literature
8.	ALA662225	B	In vitro ability to inhibit HSV DNA polymerase activity in vitro using activated calf thymus DNA as atemplate at dose 50 ug/mL	herpes simplex virus	7		nucleic acid format	Scientific Literature
9.	ALA661520	B	Concentration required for 50% decrease in fluorescence of ethidium bromide bound to calf thymus DNA. at 600 nm	Bos taurus	10		nucleic acid format	Scientific Literature
10.	ALA661551	F	Minimum inhibitory concentration required to reduce virus induced cytopathogenicity by 50% against Coxsackie type B4 virus in Vero B cell cultures	Coxsackievirus B4	7		organism-based format	Scientific Literature
11.	ALA679022	B	Inhibitory concentration against human estrogen receptor(ER) polymerase chain reaction product		7		nucleic acid format	Scientific Literature
12.	ALA677921	F	Inhibitory concentration required to inhibit murine mammary carcinoma FM3A cells proliferation	Mus musculus	18		cell-based format	Scientific Literature
13.	ALA682141	F	Inhibition of proliferation of Murine mammary carcinoma (FM3A) cells was measured	Mus musculus	8		cell-based format	Scientific Literature
14.	ALA682763	F	Evaluation for its inhibitory effect on proliferation of murine mammary carcinoma (FM3A) cells	Mus musculus	11		cell-based format	Scientific Literature
15.	ALA694658	F	Inhibitory concentration against HIV-1 LTR polymerase chain reaction product	Human immunodeficiency virus 1	7		organism-based format	Scientific Literature
16.	ALA696920	F	Compound were tested for their ability to inhibit HSV replication at their maximal nontoxic concentration	herpes simplex virus	7		organism-based format	Scientific Literature
17.	ALA693927	F	In vitro ability to inhibit synthesis of herpes simplex virus (HSV) DNA in isolated nuclei at dose 100 ug/mL	herpes simplex virus	5		organism-based format	Scientific Literature
18.	ALA872044	F	In vitro ability to inhibit synthesis of herpes simplex virus (HSV) DNA in isolated nuclei at dose 200 ug/mL	herpes simplex virus	6		organism-based format	Scientific Literature
19.	ALA693928	F	In vitro ability to inhibit synthesis of herpes simplex virus (HSV) DNA in isolated nuclei at dose 25 ug/mL	herpes simplex virus	6		organism-based format	Scientific Literature
20.	ALA693929	F	In vitro ability to inhibit synthesis of herpes simplex virus (HSV) DNA in isolated nuclei at dose 400 ug/mL	herpes simplex virus	6		organism-based format	Scientific Literature